Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jose Manuel Otero Insider Profile
4 Followers
Jose Manuel Otero, Chief Technical Officer at Lexeo Therapeutics, Inc., holds 31.25K shares in Lexeo Therapeutics, Inc. (Ticker: LXEO).
Jose Manuel Otero has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jose Manuel Otero's holdings
Insider Roles
Chief Technical Officer
Roles that Jose Manuel Otero holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jose Manuel Otero
Jose Manuel Otero's Trading History
List of latest transactions for each holding click on a transaction to see Jose Manuel Otero's performance on stock
You May Also Like
Jose Manuel Otero insider profile FAQ
What is the percentage of profitable transactions made by Jose Manuel Otero?
The percentage of profitable transactions made by Jose Manuel Otero is ―.
What is the average return per transaction made by Jose Manuel Otero?
The average return per transaction made by Jose Manuel Otero is ―.
What stocks does Jose Manuel Otero hold?
Jose Manuel Otero holds: LXEO stocks.
What was Jose Manuel Otero’s latest transaction?
Jose Manuel Otero latest transaction was an Uninformative Buy of ―.
What was Jose Manuel Otero's most profitable transaction?
Jose Manuel Otero’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jose Manuel Otero's role in Lexeo Therapeutics, Inc.?
Jose Manuel Otero's role in Lexeo Therapeutics, Inc. is Chief Technical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.